MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by BobAppleson May 28, 2020 9:23pm

259 Views

Post# 31085617

RE:One new FDA approval

My suspicion is that the FDA was caught off guard by the optics of poor accuracy for many of the tests that were approved early on. Now they need to spend addtional time to ensure test performance is understood and tests perform as advertised. I believe the statement of "Medmira is commited to gaining FDA approval" in the recent news suggests that they have been through some extra hoops that early approvals may not have needed.

But who knows.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec